Literature DB >> 9227314

Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats.

A Haczku1, P Macary, T J Huang, H Tsukagoshi, P J Barnes, A B Kay, D M Kemeny, K F Chung, R Moqbel.   

Abstract

Following allergen exposure, sensitized Brown-Norway rats develop airway hyperresponsiveness (AHR) and eosinophilic inflammation together with an increase in activated T cells (CD25+) in the airways. We tested the hypothesis that CD4+ T cells are involved directly in the acquisition of AHR. Spleen T cells from animals that were injected intraperitoneally on three consecutive days with ovalbumin/Al(OH)3, showed a dose-dependent proliferative response in vitro to ovalbumin, but not to bovine serum albumin, as measured by [3H]thymidine uptake. For total T-cell transfer, spleen cells obtained from donor rats 4 days after sensitization were depleted of adherent cells by a nylon wool column separation. CD4+ and CD8+ T cells were purified by immunomagnetic beads cell separation. Recipient naive rats were injected intravenously with 50 x 10(6) total T cells, 20 x 10(6) and 5 x 10(6) CD4+ cells, and 5 x 10(6) CD8+ cells, and were exposed to ovalbumin aerosol 24 hr afterwards. After a further 24 hr, airway responsiveness to acetylcholine (ACh) was measured and provocative concentration (PC) values PC100, PC200 and PC300) (the ACh concentration needed to achieve 100, 200 and 300% increase in lung resistance above baseline) were calculated. Airway responsiveness was significantly increased in recipients of sensitized total T cells compared with recipients of cells from saline-injected donor rats (P < 0.05). There were significantly increased eosinophil major basic protein (MBP)+ cell counts/mm2 in airway submucosal tissue in the hyperreactive rats and a significant correlation was found between the number of MBP+ cells and PC100 (r = 0.75; P < 0.03) in recipients of sensitized total T cells. Purified CD4+ T cells from sensitized donors induced AHR in naive recipients (P < 0.05), while sensitized CD8+ and naive CD4+ cells failed to do so. Our data indicate that T cells may induce AHR through an eosinophilic airway inflammation and that CD4+ T cells may have a direct effect in this process in Brown-Norway rats.

Entities:  

Mesh:

Year:  1997        PMID: 9227314      PMCID: PMC1363844          DOI: 10.1046/j.1365-2567.1997.d01-2221.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  The pathology of asthma, with special reference to changes in the bronchial mucosa.

Authors:  M S DUNNILL
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

2.  NHLBI Workshop Summary. Models of airway hyperresponsiveness.

Authors:  A Wanner; W M Abraham; J S Douglas; J M Drazen; H B Richerson; J S Ram
Journal:  Am Rev Respir Dis       Date:  1990-01

3.  Evidence of a selective major vascular marginal pool of lymphocytes in the lung.

Authors:  R Pabst; R M Binns; S T Licence; M Peter
Journal:  Am Rev Respir Dis       Date:  1987-11

4.  Changes in T-lymphocyte subpopulations after antigenic bronchial provocation in asthmatics.

Authors:  A A Gerblich; A E Campbell; M R Schuyler
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

5.  Damage of the airway epithelium and bronchial reactivity in patients with asthma.

Authors:  L A Laitinen; M Heino; A Laitinen; T Kava; T Haahtela
Journal:  Am Rev Respir Dis       Date:  1985-04

6.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

Authors:  C J Corrigan; A B Kay
Journal:  Am Rev Respir Dis       Date:  1990-04

7.  Recombinant human interleukin 5 is a selective eosinophil chemoattractant.

Authors:  J M Wang; A Rambaldi; A Biondi; Z G Chen; C J Sanderson; A Mantovani
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

8.  Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.

Authors:  E J Clutterbuck; E M Hirst; C J Sanderson
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

9.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  15 in total

1.  Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation.

Authors:  Stephen L Underwood; El-Bdaoui Haddad; Mark A Birrell; Kerryn McCluskie; Michaela Pecoraro; Dominika Dabrowski; Stephen E Webber; Martyn L Foster; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 2.  The role of the T follicular helper cells in allergic disease.

Authors:  D M Kemeny
Journal:  Cell Mol Immunol       Date:  2012-08-20       Impact factor: 11.530

3.  Inhibitory effects of endogenous and exogenous interferon-gamma on bronchial hyperresponsiveness, allergic inflammation and T-helper 2 cytokines in Brown-Norway rats.

Authors:  T J Huang; P A MacAry; T Wilke; D M Kemeny; K F Chung
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats.

Authors:  J P Hannon; B Tigani; I Williams; L Mazzoni; J R Fozard
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Effect of CD8+ T-cell depletion on bronchial hyper-responsiveness and inflammation in sensitized and allergen-exposed Brown-Norway rats.

Authors:  T J Huang; P A MacAry; D M Kemeny; K F Chung
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

6.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.

Authors:  Didier D Cataldo; Kurt G Tournoy; Karim Vermaelen; Carine Munaut; Jean-Michel Foidart; Renaud Louis; Agnès Noël; Romain A Pauwels
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma.

Authors:  Divya Mehra; David I Sternberg; Yuxia Jia; Stephen Canfield; Vincent Lemaitre; Takwi Nkyimbeng; Julie Wilder; Joshua Sonett; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-25       Impact factor: 5.464

8.  Airway hyperresponsiveness to bradykinin induced by allergen challenge in actively sensitised Brown Norway rats.

Authors:  K M Ellis; C Cannet; L Mazzoni; J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-15       Impact factor: 3.000

Review 9.  Airway remodeling: lessons from animal models.

Authors:  David Ramos-Barbón; Mara S Ludwig; James G Martin
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

Review 10.  Drug treatment of asthma in the 1990s: achievements and new strategies.

Authors:  A Tavakkoli; P J Rees
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.